Dr. Mohler on Guidelines for Recording Family History in Prostate Cancer

Video

In Partnership With:

James Mohler, MD, discusses what information should be included in a family history, based on the updated National Comprehensive Cancer Network guidelines for genetic testing in prostate cancer.

James Mohler, MD, professor of oncology, associate director, senior vice president, Translational Research, chief, Inter-Institutional Academics, Roswell Park Comprehensive Cancer Center, discusses what information should be included in a family history, based on the updated National Comprehensive Cancer Network guidelines for genetic testing in prostate cancer.

In the past, family histories have been limited, explains Mohler. A typical history in an electronic health record would express a positive or negative history, and potentially what relative had cancer, says Mohler.

However, if the patient’s relative had cancer, the family history should include the relative’s age of diagnosis, treatment received, whether they presented with or developed metastatic disease, and if they died from the disease, says Mohler. Moreover, the updated criteria also recommend including hereditary cancer mutations and syndromes, Ashkenazi Jewish status, and race.

Going forward, these criteria should be implemented in clinical practice to fully capture a patient’s family history, concludes Mohler.

Related Videos
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Vikram M. Narayan, MD, assistant professor, Department of Urology, Emory University School of Medicine, Winship Cancer Institute; director, Urologic Oncology, Grady Memorial Hospital
Stephen V. Liu, MD
S. Vincent Rajkumar, MD
Pashtoon Murtaza Kasi, MD, MS
Naseema Gangat, MBBS
Samilia Obeng-Gyasi, MD, MPH,
Kian-Huat Lim, MD, PhD
Saurabh Dahiya, MD, FACP, associate professor, medicine (blood and marrow transplantation and cellular therapy), Stanford University School of Medicine, clinical director, Cancer Cell Therapy, Stanford BMT and Cell Therapy Division
Muhamed Baljevic, MD